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Abstract
BACKGROUND/AIM: Parathyroid hormone (PTH)-dependent inhibition of proximal tubular P(i)
reabsorption is mediated by protein kinase A and/or C and is associated with reduced border membrane
expression of the type IIa Na/P(i) cotransporter. The aim of this study was to analyze phosphorylation of
the type IIa cotransporter protein. METHODS: Opossum kidney cells were used as a 'proximal tubular'
cell model. Protein phosphorylation was determined by immunoprecipitation of the type IIa Na/P(i)
cotransporter, followed by autoradiography. The transporter protein content was evaluated by Western
blotting and transport activity by tracer P(i) uptake. RESULTS: Under control conditions (no PTH) the
transporter was phosphorylated; upon treatment with PTH, a decrease in phosphorylation was observed.
A protein phosphatase inhibitor (okadaic acid) was unable to prevent PTH-induced Na/P(i) cotransporter
inhibition but reduced transporter degradation. CONCLUSION: The type IIa Na/P(i) cotransporter is a
phosphoprotein, but alterations in its phosphorylation seem not to be involved in P(i) transport
inhibition.
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Abstract
Background/Aim: Parathyroid hormone (PTH)-depen-
dent inhibition of proximal tubular Pi reabsorption is
mediated by protein kinase A and/or C and is associated
with reduced border membrane expression of the type
IIa Na/Pi cotransporter. The aim of this study was to ana-
lyze phosphorylation of the type IIa cotransporter pro-
tein. Methods: Opossum kidney cells were used as a
‘proximal tubular’ cell model. Protein phosphorylation
was determined by immunoprecipitation of the type IIa
Na/Pi cotransporter, followed by autoradiography. The
transporter protein content was evaluated by Western
blotting and transport activity by tracer Pi uptake. Re-
sults: Under control conditions (no PTH) the transporter
was phosphorylated; upon treatment with PTH, a de-
crease in phosphorylation was observed. A protein
phosphatase inhibitor (okadaic acid) was unable to pre-
vent PTH-induced Na/Pi cotransporter inhibition but re-
duced transporter degradation. Conclusion: The type IIa
Na/Pi cotransporter is a phosphoprotein, but alterations
in its phosphorylation seem not to be involved in Pi
transport inhibition.
Copyright © 2001 S. Karger AG, Basel
Introduction
Physiological alterations in renal Pi handling are asso-
ciated with changes in brush border expression of a type
IIa Na/Pi cotransporter [see ref. 1 for a review]. For exam-
ple, parathyroid hormone (PTH) decreases the brush bor-
der content of this transport protein by its specific mem-
brane retrieval and subsequent lysosomal degradation
[2].
Opossum kidney (OK) cells can be used to characterize
PTH effects on Pi transport function and on type IIa Na/
Pi cotransporter protein content/expression; protein ki-
nases C and A are involved in these regulations and lead
to Na/Pi cotransport inhibition, membrane retrieval and
lysosomal degradation of the transporter protein [1, 3–7].
In studies on the type IIa transporter expressed in oocytes,
kinase C-induced membrane retrieval has been observed
[8]; however, this was independent of known protein
kinase C and A consensus sites [9]. In a recent study on
isolated perfused mice proximal tubules, we were also
able to document the participation of protein kinases A
and C in PTH-induced brush border membrane retrieval
of the cotransporter [10].
The target proteins of PTH-activated protein kinase A
and/or C have not been defined; PTH treatment of OK
cells was shown to induce phosphorylation of proteins
present in an enriched apical membrane fraction [7].
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Fig. 1. Phosphorylation of the type IIa Na/Pi cotransporter protein.
Cells were metabolically labeled with [32P]-orthophosphate in the
presence of leupeptin and treated with PTH (10–8 M ) for 5 and 30
min. Immunoprecipitation and further analysis of the cotransporter
protein (Western blot, autoradiography) was performed as described
in Methods. Quantification of phosphorylation by phosphoimager
counting indicated dephosphorylation after PTH treatment (5 and
30 min); quantification of autoradiographs and corresponding West-
ern blots (Image quant software) resulted in an approximately 4-fold
decrease in phosphorylation for the 30 min PTH exposure. Similar
data were obtained in two additional experiments.
Ca2+- and cAMP-dependent protein phosphorylationhas
been observed in studies using isolated renal brush border
membranes [11–13]. However, phosphorylation of the
type IIa Na/Pi cotransporter protein has not been re-
ported; such modification of the transporter may be
involved in its PTH-induced inhibition, internalization
and lysosomal degradation.
In the present study, the OK cell type IIa Na/Pi co-
transporter was found to be phosphorylated in the ab-
sence of PTH; upon treatment with the hormone, dephos-
phorylation was observed. A phosphatase inhibitor did
not prevent Na/Pi cotransporter inhibition, but did re-
duce its PTH-induced degradation. Thus, altered phos-
phorylation of the cotransporter may not be involved in Pi
transport inhibition.
Methods
OK cells were grown in 35-mm plastic dishes, and Pi transport
(32Pi) was measured as previously described [4–7].
Confluent OK cells (3 dishes per experimental condition) were
washed three times and then incubated in 1 ml of phosphate-free
DMEM/Ham’s F12, 22 mM NaHCO3, 20 mM HEPES and 5% CO2
(pH 7.4) for 30 min (at 37°C) in the presence of the lysosomal inhib-
itor leupeptin (100 Ìg/ml); after addition of 32Pi (0.25 mCi/ml), the
cells were kept for 2 h at 37°C and PTH (10–8 M ) was added during
this time period as indicated. Subsequently, the cells were washed
four times with ice-cold Tris-buffered saline and harvested by scrap-
ing in lysis buffer [RIPA: 150 mM NaCl, 5 mM EDTA, 50 mM Tris,
1% Triton X-100, 0.5% sodium deoxycholate, 1% SDS and 1 mM
phenylmethyl sulfonylfluoride (PMSF)] containing also 1 mM
okadaic acid (Calbiochem) and a 1/100 diluted protease inhibitor
mix (Sigma) and 10 mM sodium pyrophosphate, 50 mM NaF, 0.2
mM sodium vanadate. After 30 min at 4°C, the suspension was cen-
trifuged for 5 min at 10,000 g. Protein A-Sepharose (50 Ìl; 50% v/v
in RIPA buffer) was used for preabsorption (30 min at 4°C) and then
collected by centrifugation for 5 min at 10,000 g. The type IIa Na/Pi
cotransporter was immunoprecipitated from the supernatants by
adding a transporter-specific antibody [5, 6] bound to protein A-
Sepharose (40 Ìl, 50% v/v) and incubating for 2 h at 4°C. Finally, the
protein A-Sepharose beads were collected by centrifugation and
washed four times with 500 Ìl of RIPA buffer. Twenty microliters of
2 ! electrophoresis loading buffer were added to the final pellets to
dissociate the proteins from the protein A-Sepharose (at 95°C). After
centrifugation, proteins in the supernatant were analyzed by SDS-
PAGE (9%) and by electrotransfer of the proteins onto nitrocellulose.
To remove incorporated phosphate, the protein A-Sepharose beads
were exposed for 90 min at 37°C to 50 Ìl of buffer [50 mM Tris-HCl,
pH 8.5, 2 mM PMSF, 8 mM MgCl2, 0.1% ß-mercaptoethanol (v/v)]
containing 20 units of calf intestinal alkaline phosphatase. After this
procedure, proteins were separated by SDS-PAGE as indicated.
Phosphorylated proteins were visualized by exposing the dried nitro-
cellulose membranes to Kodak X-Omat films at –70°C for various
time periods. Immunodetection of the cotransporter protein (same
nitrocellulose membrane as used for the 32P autoradiography) was
performed as previously described [5, 6].
Results and Discussion
Protein kinase A- and/or C-mediated phosphorylation
of the OK cell type IIa Na/Pi cotransporter might be
involved in PTH-induced Pi transport inhibition and may
also be the ‘initial event’ in its subsequent internalization
and degradation [5, 6] (see Introduction). To prevent
PTH-induced degradation of the transporter [5, 6, 10], the
present experiments on protein phosphorylation had to be
performed in the presence of an inhibitor of lysosomal
degradation (leupeptin). Furthermore, to detect the ‘ini-
tial event’, we exposed cells for only 5 or 30 min to PTH
or vehicle alone (fig. 1).
In previous studies [6], we have shown that the trans-
porter is under control conditions (no PTH, no lysosomal
inhibitor) mainly present at the apical cell surface; only in
the presence of the inhibitor can it be detected in lysosom-
al compartments. For technical reasons (amount of 32Pi
required to obtain sufficient labeling; see Methods), in the
present study we were only able to use small amounts of
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cell material per experimental condition, insufficient for
cell fractionation experiments. We assume that a signifi-
cant amount of the transporter protein recovered from the
cell lysates was at the apical cell surface prior to addition
of PTH [6]. Therefore, our data on protein phosphoryla-
tion should allow conclusions on the hypothetical role of
phosphorylation in the control of apical expression and
function of this transporter.
In immunological detections, the cotransporter protein
appeared in the immunoprecipitates as strong stainings at
90–120 kD [5, 6]. In the autoradiographs, phosphoryla-
tion signals were obtained at the corresponding molecular
weight (90–120 kD; fig. 1). The phosphorylation could be
removed by exposing the precipitated proteins to alkaline
phosphatase treatment prior to SDS-PAGE and autoradi-
ography (data not shown; see Methods). As phosphoryla-
tion was observed in the absence of PTH, it can be con-
cluded that the cotransporter is phosphorylated under
‘basal’ conditions. PTH did not induce an increase but
rather a decrease in phosphorylation of the cotransporter
after 5 or 30 min of exposure to the hormone (fig. 1).
Phosphoimager counting and quantification of autoradio-
graphs and Western blots (Image quant software) resulted
in 3 experimental repetitions in dephosphorylations (2- to
4-fold) of the cotransporter in response to the above short-
term exposure to PTH. As PTH effects are mimicked by
pharmacological activators or prevented by inhibitors of
protein kinase A and/or C [5, 10], it seems likely that the
observed PTH-independent phoshorylation is not a result
of such kinase activation. Obviously, these kinases also
cannot be ‘directly’ involved in the observed dephospho-
rylations.
The above-mentioned dephosphorylation might be ex-
plained by at least two separate processes. Firstly, under
PTH treatment, a protein phosphatase activity can be
activated. Secondly, PTH shifts the transporter to the
lysosomes [2, 5, 6], where it can undergo dephosphoryla-
tion. The involvement of a specific dephosphorylation
reaction in PTH-induced Pi transport inhibition was stud-
ied by an analysis of the effect of inhibitors of protein
phosphatase activities. We used okadaic acid (10–7 M), as
a widely used inhibitor of protein phosphatases, in cells
treated (data not shown) or not treated with leupeptin
(fig. 2). Okadaic acid had no effect on Na/Pi cotransport
activity or its PTH-dependent inhibition in the presence
(data not shown) and absence of leupeptin (fig. 2, upper
panel). In contrast, in cells not treated with leupeptin,
PTH-induced transporter degradation was found to be
reduced in the presence of okadaic acid (fig. 2, lower
panel; approximately 60 vs. 35%). We also used calyculin
Fig. 2. Na/Pi cotransport activity (upper panel) and expression of the
type IIa NaPi cotransporter (lower panel) in the presence or absence
of okadaic acid (OA): effect of PTH. Cells were incubated with PTH
(10–8 M ) in the absence of leupeptin and with or without okadaic
acid (10–7 M ) for 1 h. Then, Na/Pi cotransport activity was measured
and transport protein was determined by Western blotting. Trans-
port activity in control and PTH-exposed cells was unaffected by the
presence of okadaic acid during the 1-hour incubation in the pres-
ence or absence of the hormone. Quantification of the Western blots
indicated an approximately 60% decrease in response to PTH, which
was reduced to an approximately 35% decrease in the presence of
okadaic acid. Similar data were obtained in two additional experi-
ments.
A (10–8 M) as proteinphosphatase inhibitor and observed
similar results (data not shown). These data suggest that
PTH-induced dephosphorylation does not participate in
the mechanisms leading to transport inhibition. The
(weak) effect of phosphatase inhibitors on the PTH-
induced degradation of the transporter might involve spe-
cific or unspecific actions of the inhibitors at a stage
beyond transport inhibition, i.e. membrane internaliza-
tion and/or delivery to the lysosomes, including effects on
the cytoskeleton.
In conclusion, the OK cell type IIa Na/Pi-cotransporter
is a phosphoprotein, and PTH does not increase, but rath-
er decreases its phosphorylation state. Thus, a phosphory-
lation/dephosphorylation step seems not to be involved in
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PTH-dependent control of the apical expression and
transport activity of this transporter. The possibility has
to be considered that PTH-induced phosphorylation
might occur at the level of proteins interacting specifically
with this transporter [14].
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